Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04320511 · ClinicalTrials.gov registry record
Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
A clinical trial, sponsored by Corewell Health East.
- Terminated
- Registry status
- 15
- Enrollment target
NCT04320511 is a clinical trial that was terminated before completion, run by Corewell Health East. The registered enrollment target is 15 participants.
The verdict
NCT04320511 was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate if CT (Computerized Tomography) can effectively and accurately predict disease progression in patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). You may be eligible if you have been diagnosed with SARS-CoV-2, are an inpatient at Beaumont Hospital-Royal Oak and meet eligibility criteria. After consent and determination of eligibility, enrolled patients will have a CT scanning session. After the CT scan, patients are followed for 30 days by reviewing their medical records and by phone after discharge from hospital.
Interventions
- DEVICE CT-V
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-06-24 |
| Est. Completion | 2021-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04320511
The ClinicalTrials.gov registry entry for NCT04320511 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT-V is the first listed.
NCT04320511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04320511 about?
NCT04320511 is a clinical study titled "Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2". The goal of this study is to evaluate if CT (Computerized Tomography) can effectively and accurately predict disease progression in patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). You may be eligible if you have been diagnosed with SARS-CoV-2, are an inpatient at Beaumont...
What is the current status of trial NCT04320511?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2020-06-24. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT04320511?
The interventions under investigation include: CT-V (DEVICE).
Who is sponsoring clinical trial NCT04320511?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.